Abeona Therapeutics Inc SMA 200
Что обозначает SMA 200 в Abeona Therapeutics Inc?
SMA 200 Abeona Therapeutics Inc является $6 +0.08%
Какое определение для SMA 200?
SMA 200 - это средняя цена акций за последние 200 дней, рассчитанная как невзвешенное среднее значение предыдущих 200 цен закрытия акций.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 компаний в Health Care сектор на NASDAQ по сравнению с Abeona Therapeutics Inc
Что делает Abeona Therapeutics Inc?
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Компании с sma 200 похож на Abeona Therapeutics Inc
- Applied Dna Sciences Inc имеет SMA 200 из $6 -269.28%
- Voya International High Dividend Equity Income Fund имеет SMA 200 из $6 +0.00%
- MDC Partners имеет SMA 200 из $6 -2.95%
- Riskified имеет SMA 200 из $6 -21.88%
- Ferratum Oyj имеет SMA 200 из €6 -12.67%
- Zevra Therapeutics Inc имеет SMA 200 из $6 +3.90%
- Abeona Therapeutics Inc имеет SMA 200 из $6 +0.08%
- Biodelivery Sciences International имеет SMA 200 из $6 +0.00%
- Antares Pharma Inc имеет SMA 200 из $6 +0.00%
- Chesswood имеет SMA 200 из CAD$6 -521.14%
- Lantern Pharma имеет SMA 200 из $6 -50.31%
- Nuveen Credit Strategies Income Fund имеет SMA 200 из $6 +5.37%
- IMP Powers имеет SMA 200 из ₨6 +0.00%